by Madaline Spencer | Jul 12, 2024
Mario Maldonado, MD, Head of Clinical Development for Global Endocrinology at Recordati Rare Diseases, discusses current treatment options for patients with Cushing’s syndrome. Cushing’s syndrome is a rare endocrine disorder caused by prolonged...
by Madaline Spencer | Jul 11, 2024
Kate Stratton, Program Coordinator for Lipodystrophy United, discusses the need for psychosocial support for patients with lipodystrophy. Lipodystrophies are rare metabolic disorders characterized by the loss of adipose tissue. This leads to...
by Madaline Spencer | Jul 10, 2024
Diego Ferone, MD, PhD, University of Genoa and Chief of the Endocrine Unit at San Martino Hospital, discusses a novel octreotide formulation for the treatment of acromegaly. Acromegaly is a rare endocrine disorder that results from the overproduction of...
by Madaline Spencer | Jul 9, 2024
The U.S. Food and Drug Administration (FDA) has approved Epkinly (epcoritamab-bysp) for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy. Follicular lymphoma is a form of...
by Madaline Spencer | Jul 9, 2024
Diane Schriner, Vice President of Erdheim-Chester Disease Global Alliance, provides an overview of Erdheim-Chester disease (ECD). ECD is a rare blood cancer characterized by the overproduction of histiocytes, which then accumulate in tissues and organs....
